Results 31 to 40 of about 60,209 (283)

Sirolimus-induced pneumonitis

open access: yesIndian Journal of Nephrology, 2009
A 15 year-old girl with reflux nephropathy ESKD underwent a related renal transplant in March 2000. Initial immunoupprressants administered to the patient included cyclosporine, azathioprine, and prednisolone. In January 2003, she had acute allograft dysfunction due to CNI toxicity with chronic allograft nephropathy (CAN) detected by biopsy.
Sanjiv Jasuja, A K Gupta, U Singh
openaire   +3 more sources

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review

open access: yesActa Dermato-Venereologica, 2019
Vascular anomalies (VAs) may be associated with significant morbidity and mortality. The aim of this study was to evaluate the efficacy and safety of sirolimus (rapamycin) in the treatment of children and young adults with complicated VAs.
Shira Sandbank   +4 more
doaj   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation

open access: yesClinical Transplantation, Volume 36, Issue 11, November 2022., 2022
Abstract Background We reviewed the scientific literature to gain insight on the epidemiology and outcome of Strongyloides stercoralis infections after transplantation. Methods CINAHL, PUBMED, and OVID/MEDLINE were reviewed from inception through March 31, 2022 using key words Strongyloides and transplantation.
Cybele Lara R. Abad   +3 more
wiley   +1 more source

Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]

open access: yes, 2012
Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A   +7 more
core   +2 more sources

Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants [PDF]

open access: yes, 2022
Aims Management of kaposiform haemangioendotheliomas (KHE) with Kasabach-Merritt phenomenon is challenging in young infants who are subjected to developmental pharmacokinetic changes.
Fuijkschot, Joris   +8 more
core   +1 more source

Ovarian Toxicity from Sirolimus [PDF]

open access: yesNew England Journal of Medicine, 2012
Low-dose oral sirolimus appears to increase the risk of menstrual-cycle disturbances and ovarian cysts. Monitoring patients for sirolimus-associated ovarian toxicity may be considered.
Braun Matthias   +5 more
openaire   +3 more sources

Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial

open access: yesClinical Transplantation, Volume 36, Issue 12, December 2022., 2022
Abstract Background After liver transplantation (LT), tacrolimus and ciclosporin treatment can lead to, partially concentration‐dependent, chronic kidney disease. Monitoring ciclosporin with two‐hour levels reduced overexposure and led to better renal function than trough‐monitoring (C0).
Bastian N. Ruijter   +4 more
wiley   +1 more source

Liquid chromatography-tandem mass spectrometry - Application in the clinical laboratory [PDF]

open access: yes, 2003
This review provides a concise survey of liquid chromatography tandem mass spectrometry (LCTMS) as an emerging technology in clinical chemistry. The combination of two mass spectrometers with an interposed collision cell characterizes LCTMS as an ...
Ford RE   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy